This article is published in association with United Nations. The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries. The spurious semaglutides – of a specific brand Ozempic […]UN health agency issues alert on falsified medicines used for diabetes treatment, weight loss
June 21, 2024 by Leave a Comment
This article is published in association with United Nations. The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries. The spurious semaglutides – of a specific brand Ozempic […]Weight loss drugs are not the only answer: Why we must redefine the obesity journey
January 11, 2024 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Glen Tullman, Founder and Chief Executive Officer, Transcarent The problem The disease of obesity has reached pandemic status. According to the World Obesity Foundation, more than half of the world’s population is expected to be overweight or obese by 2035 and the […]
